Author details

Full Name

Jun Qin

Affiliation

ORCID

Career Start Year

1994

Papers

279

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36788224	Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer.	Nat Commun	2023
37674236	Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics.	Genome Biol	2023
36907503	Expanding individualized therapeutic options via genoproteomics.		2023
36824285	Global profiling of AMG510 modified proteins identified tumor suppressor KEAP1 as an off-target.		2023
36507562	SCD1 Sustains Homeostasis of Bulge Niche via Maintaining Hemidesmosomes in Basal Keratinocytes.	Adv Sci (Weinh)	2023
37142671	SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches.		2023
36959211	Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-Î² growth-suppressive signaling in BCR-ABL1-positive leukemia.		2023
37459541	Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.	Proc Natl Acad Sci U S A	2023
37258779	High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer.		2023
36747266	Transcriptomics-proteomics Integration reveals alternative polyadenylation driving inflammation-related protein translation in patients with diabetic nephropathy.	J Transl Med	2023
36680394	Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression.		2023
35235781	Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer.	Cell Reports	2022
35530287	Dynamic proteomic change of tumor and immune organs in an immune-competent hepatocellular carcinoma mouse model.	American Journal of Cancer Research (discontinued)	2022
36356476	Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer.	eBioMedicine	2022
35641500	The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness.	Nature Communications	2022
35568718	Ezh2 competes with p53 to license lncRNA Neat1 transcription for inflammasome activation.	Cell Death and Differentiation	2022
36276637	Identifying the E2F3-MEX3A-KLF4 signaling axis that sustains cancer cells in undifferentiated and proliferative state.	Theranostics	2022
35731873	Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes.	Science advances	2022
35792948	Urinary protein biomarker panel predicts esophageal squamous carcinoma from control cases and other tumors.	Esophagus	2022
36384137	AMPK directly phosphorylates TBK1 to integrate glucose sensing into innate immunity.	Molecular Cell	2022
36450731	Integrated proteomic and transcriptomic landscape of macrophages in mouse tissues.	Nat Commun	2022
35301141	Dynamic EGFR interactomes reveal differential association of signaling modules with wildtype and Exon19-del EGFR in NSCLC cell lines.	Journal of Proteomics	2022
35290573	A urinary proteomic landscape of COVID-19 progression identifies signaling pathways and therapeutic options.	Sci China Life Sci	2022
34818622	Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer.	eBioMedicine	2021
33972635	Endoplasmic reticulum stress regulates the intestinal stem cell state through CtBP2.	Scientific Reports	2021
34280886	MTA2 sensitizes gastric cancer cells to PARP inhibition by induction of DNA replication stress.	Translational Oncology	2021
33531669	Author Correction: ALK phosphorylates SMAD4 on tyrosine to disable TGF-Î² tumour suppressor functions.	Nature Cell Biology	2021
34258712	Proteomics provides individualized options of precision medicine for patients with gastric cancer.	Science China Life Sciences	2021
34097653	Detecting Periprosthetic Joint Infection by Using Mass Spectrometry.	Journal of Bone and Joint Surgery	2021
33504946	Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation asÂ theÂ receptor protein of CRL2 complex.	Cell Death and Differentiation	2021
34351703	Proteome-Wide Profiling of Readers for DNA Modification.	Advanced Science	2021
34626540	Low-density-lipoprotein-receptor-related protein 1 mediates Notch pathway activation.	Dev Cell	2021
34404448	Quantifying the phase separation property of chromatin-associated proteins under physiological conditions using an anti-1,6-hexanediol index.	Genome Biol	2021
34963468	Urine proteomics identifies biomarkers for diabetic kidney disease at different stages.	Clinical Proteomics	2021
32509390	NQO1 is a determinant for cellular sensitivity to anti-tumor agent Napabucasin.	American Journal of Cancer Research (discontinued)	2020
32135178	Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis.	J Hepatol	2020
32314919	Phosphoproteomics Analysis Reveals a Potential Role of CHK1 in Regulation of Innate Immunity through IRF3.	J Proteome Res	2020
31887055	Comparative Proteomic Analysis of Histone Modifications upon Acridone Derivative -Induced CCRF-CEM Cells by Data Independent Acquisition.	Journal of Proteome Research	2020
32051188	A time-resolved multi-omic atlas of the developing mouse liver.	Genome Research	2020
31762063	PLK4 deubiquitination by Spata2-CYLD suppresses NEK7-mediated NLRP3 inflammasome activation at the centrosome.	EMBO Journal	2020
32337245	Discovery of Urinary Proteomic Signature for Differential Diagnosis of Acute Appendicitis.	Biomed Res Int	2020
32826889	OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity.	Nature Communications	2020
32764536	The REGÎ³ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells.	Nat Commun	2020
32649877	Integrative Proteomic Characterization of Human Lung Adenocarcinoma.	Cell	2020
32592085	Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?	Science China Life Sciences	2020
32968062	Author Correction: The REGÎ³ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells.	Nat Commun	2020
32519869	Time- and Dose-Resolved Proteome of PM-Exposure-Induced Lung Injury and Repair in Rats.	Journal of Proteome Research	2020
33338401	A Surge of DNA Damage Links Transcriptional Reprogramming and Hematopoietic Deficit in Fanconi Anemia.	Mol Cell	2020
33171123	TBK1-Mediated DRP1 Targeting Confers Nucleic Acid Sensing to Reprogram Mitochondrial Dynamics and Physiology.	Molecular Cell	2020
31442056	A Cross-Linking-Aided Immunoprecipitation/Mass Spectrometry Workflow Reveals Extensive Intracellular Trafficking in Time-Resolved, Signal-Dependent Epidermal Growth Factor Receptor Proteome.	Journal of Proteome Research	2019